BHVN Biohaven Pharmaceutical Holding Co

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.

$84.03  +6.16 (7.91%)
As of 03/05/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
British Virgin Islands
05/04/2017
61,915,440
515,376
$5,202,754,423
0.00%
SEC Edgar Online
10-Q
10-K
G11196105
VGG111961055
BZ8FXC4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-6.79
40.23
81.77
196.43%
-1,205.14%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy